May 15, 2026:

• Medical Psilocybin Advisory Board Meeting - May 15, 2026

April 24, 2026:

• Medical Psilocybin Advisory Board Meeting - April 24, 2026

March 20, 2026:

• Presentation - MPP Advisory Board (3/20/26)
• Meeting Minutes - MPP Advisory Board (3/20/26)
• Medical Psilocybin Advisory Board Meeting - March 20, 2026

January 16, 2026:

• Presentation - MPP Advisory Board (1/16/26}
• Public Comments - MPP Advisory Board (1/16/26)
• Initial Qualifying Conditions - MPP Advisory Board (1/16/26)
• Meeting Minutes - MPP Advisory Board (1/16/26)
• Medical Psilocybin Meeting Recording - 01/16/26

December 12, 2025:

• Meeting Agenda & How to Join - MPAB 12/12/25
• Medical Psilocybin Meeting Recording - 12/12/25
• Meeting Minutes - Pending Board Approval
• Medical Psilocybin Advisory Board Committee Structure
• Medical Psilocybin Advisory Board Bylaws

December 5, 2025:

• Medical Psilocybin Meeting Recording - 12/5/25
• Meeting Minutes - MPAB 12/05/25

May 8, 2026:

Research and Continuous Improvement (RACI):

• RCIC Committee Recording - May 8, 2026

Training and Education (TE), End of Life Care (EOLC):

• Education & Training Committee Recording - May 8, 2026

May 5, 2026:

Dosage, Administration, and Clinical Practice (DACP):

• Dosage, Administration & Clinical Practice Committee Meeting Recording - May 5, 2026

May 4, 2026:

Patient Qualification & Safety (PQS):

• Patient Qualification and Safety Considerations Committee - May 4, 2026

April 28, 2026:

Equity, Access, and Cultural Considerations (EACC):

• Equity, Access, and Cultural Considerations Committee Meeting Recording - April 28, 2026

April 27, 2026:

Dosage, Administration, and Clinical Practice (DACP):

• Dosage, Administration & Clinical Practice Committee Meeting Recording - April 27, 2026

April 23, 2026:

End of Life Care:

• Medical Psilocybin Advisory Board Meeting - April 23, 2026

April 20, 2026:

Patient Qualifications & Safety:

• Medical Psilocybin Advisory Board Meeting - April 20, 2026

April 15, 2026:

Propagation:

• Medical Psilocybin Advisory Board Meeting - April 15, 2026

April 13, 2026:

Dosage, Administration, and Clinical Practice:

• Medical Psilocybin Advisory Board Meeting - April 13, 2026

April 23, 2026:

Research and Continuous Improvement:

• Medical Psilocybin Advisory Board Meeting - April 10, 2026

Training and Education

• Medical Psilocybin Advisory Board Meeting - April 10, 2026 - Part 2

April 6, 2026:

Patient Qualification & Safety:

• Medical Psilocybin Advisory Board Meeting - April 6, 2026

March 30, 2026:

• Dosage, Administration, and Clinical Practice:
• Agenda - EACC (3/24/26)
• Meeting Minutes - EACC (3/24/26)
• Dosage, Administration & Clinical Practice Committee - March 30, 2026

March 24, 2026:

• Equity, Access, and Cultural Considerations:
• Agenda - EACC (3/24/26)
• Meeting Minutes - EACC (3/24/26)
• Equity, Access, and Cultural Considerations Committee - March 24, 2026

March 20, 2026:

• End of Life Care:
• Death Doulas & Medical Psilocybin
• Meeting Minutes - EOL Care (3/20/26)
• Equity, Access, and Cultural Considerations Committee - March 24, 2026

March 18, 2026:

• Propagation:
• Propagation - Disciplinary Action and Appeal Process
• Meeting Minutes - Propagation (3/18/26)
• End of Life Care Committee - March 20, 2026

March 17, 2026:

• Patient Qualification and Safety:
• PQS - Medication Interactions
• PQS - Consolidated Recommendations
• Meeting Minutes - PQS (3/17/26)
• Patient Qualification and Safety Considerations Committee - March 17, 2026

March 16, 2026:

• Dosage, Administration, and Clinical Practice:
• Presentation - DACPC (3/16/26)
• DACPC Preparation Session Standards
• Meeting Minutes - DACPC (3/16/26)
• Psilocybin Dosage, Administration & Clinical Practice Committee - March 16, 2026

March 11, 2026:

• Equity, Access, and Cultural Considerations:
• Agenda - Equity, Access, and Cultural Considerations (3/11/2026)
• Meeting Minutes - Equity, Access, and Cultural Considerations (3/11/2026)
• Equity, Access, and Cultural Considerations Committee Recording - March 11, 2026
• Propagation:
• Agenda - Propagation (3/11/26)
• Meeting Minutes - Propagation (3/11/26)
• Propagation Committee Recording - March 11, 2026

March 4, 2026:

• Patient Qualification & Safety:
• Presentation - PQS (3/4/26)
• Meeting Minutes - PQS (3/4/26)
• MPP - Psychiatric & Neurological Considerations
• Tier 4 Not Appropriate at This Time
• Patient Qualification & Safety Committee Recording - March 4, 2026
• Research and Continuous Improvement:
• Presentation - RCIC (3/4/26)
• Meeting Minutes - RCIC (3/4/26)
• RCIC Committee Recording - March 6, 2026
• Training & Education:
• Presentation - Education & Training
• Meeting Minutes - Education & Training
• Education & Training Committee Recording - March 6, 2026

February 27, 2026:

• General:
• Presentation - MPP Advisory Board (2/27/26)
• Meeting Minutes - MPP Advisory Board (2/27/26)
• Presentation - EOL (2/27/26)
• Propagation Outline (2/27/26)
• Advisory Board Meeting Recording - February 27, 2026
• Dosage, Administration & Clinical Practice:
• Presentation - DACPC (2/20/26)
• Meeting Minutes - DACPC (2/20/26)
• MPP Dosage Guidelines - 2026
• DACPC Committee Recording - February 27, 2026

February 20, 2026:

• Patient Qualification & Safety:
• Agenda - PQS (2/20/26)
• Meeting Minutes - PQS (2/20/26)
• Patient Qualification & Safety Committee Recording - February 20, 2026
• MPP Clinical Support Tiers
• Draft Exclusion Criteria
• Medical Psilocybin - Qualifying Conditions
• End Of Life Care:
• Meeting Minutes - EOLC (2/20/26)
• End-of-Life Care Committee Recording - February 20, 2026

February 18, 2026:

• Propagation:
• Agenda - Propagation (2/18/26)
• Meeting Minutes - Propagation (2/18/26)
• Propagation Committee Recording - February 18, 2026

February 11, 2026:

• Propagation:
• Agenda - Propagation (2/11/26)
• Meeting Minutes - Propagation (2/11/26)
• Propagation Committee Recording - February 11, 2026

February 4, 2026:

• Equity, Access, and Cultural Considerations:
• Meeting Minutes - Equity, Access, and Cultural Considerations (2/4/2026)
• Equity, Access and Cultural Considerations Committee - February 2, 2026)
• Propagation:
• Agenda - Propagation (2/4/26)
• Meeting Minutes - Propagation (2/4/26)
• Propagation Committee Recording - February 4, 2026
• Propagation Outline - 2/4/26
• State Residency “Sunset Clause” Proposal

January 30, 2026:

• Dosage, Administration & Clinical Practice:
• Meeting Minutes - Dosage, Administration, & Clinical Practice (1/30/26)
• Dosage, Administration, and Clinical Practice Committee - January 30, 2026
• Dosage Definitions
• DACPC Presentation - 1/30/26
• Propagation:
• Agenda - Propagation 1/30/26
• Meeting Minutes - Propagation (1/30/26)
• Propagation Committee Recording - January 30, 2026

January 23, 2026:

• Research and Continuous Improvement:
• Meeting Minutes - RCI (1/23/26)
• Research and Continuous Improvement Committee Recording - January 23, 2026
• Presentation – RCI (1/23/26)
• Education and Training:
• Meeting Minutes - Education and Training (1/23/26)
• Education and Training Recording - January 23, 2026
• Presentation - Education and Training (1/23/26)
• Education and Training Psilocybin Committee Working Document
• Training Requirements Qualitative Analysis - Healing Advocacy Fund

January 22, 2026:

• End of Life Care:
• Meeting Minutes - EOL Care Committee (1/22/26)
• End of Life Care Committee Recording - January 22, 2026

January 21, 2026:

• Propagation:
• Agenda - Propagation (1/21/26)
• Meeting Minutes - Propagation (1/21/26)
• Psilocybin Propagation and Production Framework - (1/16/26)
• Propagation Committee Recording - January 21, 2026

January 20, 2026:

• Equity Access and Cultural Consideration:
• Meeting Minutes - Equity, Access, and Cultural Considerations (1/20/2026)
• Equity, Access, and Cultural Considerations Committee Recording - January 20, 2026

January 14, 2026:

• Dosage, Administration, & Clinical Practice:
• Meeting Minutes - Dosage, Administration, & Clinical Practice (1/14/26)
• Presentation - DACPC (1/14/26)
• Psilocybin Dosage, Administration, & Clinical Practice Committee Bylaws
• Medical Psilocybin DACPC Meeting Recording - 01/14/26

January 9, 2026:

• Research and Continuous Improvement:
• Meeting Minutes - Research and Continuous Improvement (1/9/26)
• Presentation - Research and Continuous Improvement (1/9/26)
• Research and Continuous Improvement Committee Recording - January 9, 2026
• Propagation
• Agenda - Propagation (1/9/26)
• Meeting Minutes - Propagation (1/9/26)
• Psilocybin Propagation Committee Bylaws
• Psilocybin Propagation Committee Scope of Responsibilities
• Propagation Committee Recording - January 9, 2026

January 8, 2025:

• End of Life Care - 1/8/26
• Meeting Minutes - EOL Care Committee (1/8/26)
• Presentation - EOL Care Committee (1/8/26)
• End of Life Care Committee Bylaws
• End of Life Care Committee Recording - January 8, 2026

January 7, 2025:

• Equity, Access, and Cultural Considerations 1/7/2026
• Meeting Minutes - Equity, Access, and Cultural Considerations (1/7/2026)
• Equity, Access, and Cultural Considerations Committee Recording - January 7, 2026

January 2, 2026:

• Patient Qualification & Safety:
• Patient Qualification & Safety Committee - 01/02/26
• Meeting Minutes: Coming soon
• Initial Qualifying Conditions: Coming soon
• Committee Bylaws: Coming soon
• Equity, Access, and Cultural Considerations:
• Equity, Access, and Cultural Considerations Committee Recording - 01/02/26